Abstract CT201: Early report of a phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19 (NCT04365101)

2021 ◽  
Author(s):  
Corey Casper ◽  
Leonid Groysman ◽  
Vinay Malhotra ◽  
Eric Whitman ◽  
Stacy Herb ◽  
...  
Keyword(s):  
Stem Cell ◽  
Natural Killer Cells ◽  
Phase I ◽  
Natural Killer ◽  
Hematopoietic Stem Cell ◽  
Early Report ◽  
Killer Cells ◽  
Hematopoietic Stem

Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation

2004 ◽  
Vol 33 (3) ◽  
pp. 216-221 ◽  
Author(s):  
Loredana Ruggeri ◽  
Marusca Capanni ◽  
Antonella Mancusi ◽  
Elena Urbani ◽  
Katia Perruccio ◽  
...  
Keyword(s):  
Stem Cell ◽  
Natural Killer Cells ◽  
Hematopoietic Stem Cell Transplantation ◽  
Stem Cell Transplantation ◽  
Natural Killer ◽  
Cell Transplantation ◽  
Hematopoietic Stem Cell ◽  
Killer Cells ◽  
Hematopoietic Stem

Alloreactive natural killer cells in hematopoietic stem cell transplantation

2011 ◽  
Vol 35 (1) ◽  
pp. 14-21 ◽  
Author(s):  
Hollie J. Pegram ◽  
David S. Ritchie ◽  
Mark J. Smyth ◽  
Andres Wiernik ◽  
H. Miles Prince ◽  
...  
Keyword(s):  
Stem Cell ◽  
Natural Killer Cells ◽  
Hematopoietic Stem Cell Transplantation ◽  
Stem Cell Transplantation ◽  
Natural Killer ◽  
Cell Transplantation ◽  
Hematopoietic Stem Cell ◽  
Killer Cells ◽  
Hematopoietic Stem
Sign in / Sign up

Export Citation Format

Share Document